1. Introduction {#sec1}
===============

Yinchensini decoction (YCSND) is a classical traditional Chinese medicine (TCM) prescription which has originated and been in usage since Song dynasty. YCSND is composed of four Chinese medicinal herbs, namely, Artemisiae scopariae herba (*Yinchen*), Radix aconiti Carmichael (*Fuzi*), Rhizoma zingiberis (*Ganjiang*), and Liquorice (*Gancao*). Pharmacologic studies have shown that Yinchen and Gancao have an effect on protecting liver and opposing hepatitis virus and also have the cholagogue action and anti-inflammatory effect. Then, Fuzi has effects in enhancing immunity, combating inflammation, and easing pain, and Ganjiang plays a part in protecting the liver, benefitting the bile, improving blood circulation, and stopping vomiting \[[@B1], [@B2]\]. Moreover, a preexisting experimental study has shown that YCSND has been extensively put into clinical use for the treatment of Yin jaundice and liver diseases \[[@B3]\]. Chinese herbal compound prescription is composed of many different compounds with various structures and functions, and it is unscientific that a specific effective chemical compound contains its entire medicinal value. Many components act on its mechanism through multiple targets instead of a specific target. As far as known, experimental studies of YCSND have been reported, but the specific mechanism is not fully clear. Thus, to illustrate its mechanism more systematically and comprehensively, this research intends to analyze and expound the potential molecular mechanism of YCSND based on system pharmacology. As an emerging discipline, systems pharmacology includes many disciplines such as systems biology, pharmacology, computational biology, and network analysis, which to a great degree break the traditional framework (drug-target-disease)\[[@B4]\]. Constructing a multilevel network (disease-phenotype-gene-drug) and exploring the correlation between drugs and disease from the perspective of the whole, which has the characteristics of wholeness and systematicness, correspond with the principle of a holistic view and dialectical treatment of TCM.

Therefore, based on the characteristics and methods of system pharmacology, the analysis of the existing data and the collation of target points and their chemical molecules are carried out. Through analyzing the potential interaction between the various target points, the network of target points is constructed. Then the analysis of associated pathological pathways and the summary of the potential mechanism of YCSND are achieved.

2. Materials and Methods {#sec2}
========================

2.1. Constructing Database of Candidate Compounds {#sec2.1}
-------------------------------------------------

In the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform (<http://lsp.nwu.edu.cn/tcmsp.php>,TCMSP), five constituents of Yinchensini decoction are retrieved. A total of 106 compounds are achieved. Each candidate\'s druggability was analyzed according to its oral bioavailability (OB) and drug-likeness (DL) indices recommended by TCMSP. OB refers to the degree and speed of absorbing drugs into the circulatory system, which is an important indicator to evaluate the intrinsic quality of drugs objectively. The higher the OB of the compound is, the more likely the compound is to be developed for clinical application. DL is the sum of the pharmacokinetic properties and safety, which comes from the interactions of physicochemical properties and structural factors, including solubility, permeability, and stability. It can be used to optimize compounds, analyze the results of drug activity, predict in vivo pharmacokinetics, direct structure modifications, etc. As TCMSP recommends, the molecules with OB≥30% and DL≥0.18 were considered to exhibit relatively better pharmacologically and were screened out as candidate compounds for further analysis.

2.2. Constructing the Network of Compound-Target {#sec2.2}
------------------------------------------------

To comprehensively understand the molecular mechanisms, the compound-target networks were constructed using Cytoscape visualization software 3.5.1. All the candidate compounds were retrieved in TSMSP to obtain associated targets. Then, compounds and targets were inputted into the software and compound-target interaction network was carried out. In the process of constructing the network, the layout algorithm (attribute circle layout) was applied. Users can set the geometric position of every node and display visually network topology using color, graphics, symbols, making reasonable arrangements of every node and creating a clear visual effect. Degree and betweenness centrality are two important parameters of the topology structure, which were used to evaluate the essentiality of each target and compound. Therefore, targets and compounds that play a key role in the mechanisms of Yinchensini decoction were revealed and analyzed.

2.3. Conducting PPI Network {#sec2.3}
---------------------------

Since the chances of proteins achieving assigned functions individually are small, which means proteins involved in the biochemical process in the same cell tend to form macromolecular complexes through the interactions to complete biological functions; so, the exploration of protein interactions and the interaction network is the viral procedure of understanding cellular organization, bioprocess, and functions. In order to better understand protein interactions systematically, associated targets were input to STRING 10.5 (Search Tool for the Retrieval of Interacting Genes/Proteins) to obtain relevant information of protein interaction. STRING is a commonly used system for retrieval or prediction of protein-protein interaction, known interaction, predicted interaction, and others included. The network nodes represent proteins, and edges represent protein-protein associations. Its results are derived from experimental data, literature mining, databases, and bioinformatics projections. The scoring mechanism of the system itself can score the results from different paths, and the higher the score is, the higher the confidence of the protein action information is. To ensure high confidence information, the minimum score was set to the highest confidence as 0.9. Also, disconnected proteins in the network were excluded. Last, PPT network was exported and, according to it, statistics of protein interactions were carried out.

2.4. Gene Ontology (GO) Functional Enrichment Analysis {#sec2.4}
------------------------------------------------------

Gene Ontology (GO) Consortium database is established by Gene Ontology Consortium, which can describe and limit the functions of genes, and is applicable to all species. The object of this study is a group of genes, and if they are directly annotated, the number of functional nodes obtained is large and overlapping, which results in redundancy. Therefore, the data were analyzed by functional enrichment. The method can effectively identify biological processes related to biological phenomena and is useful for obtaining more meaningful gene functional information. GO enrichment analysis was performed using the functional annotation tool of DAVID (Database for Annotation, Visualization, and Integrated Discovery). Before the enrichment, protein names of all targets were converted into corresponding gene names in the website of UniProt, and then gene names were imported into DAVID to acquire GO enrichment analysis.

2.5. KEGG Pathway Enrichment Analysis {#sec2.5}
-------------------------------------

KEGG ((Kyoto Encyclopedia of Genes and Genomes) is a database developed by University of Tokyo and Kyoto University, Japan, which provides query path databases. The identification codes converted from UniProt were imported DAVID access database. Next, the pathway enrichment of all protein genes was conducted, and the KEGG pathway annotations were analyzed, to explore biological pathways which related proteins were involved in.

3. Results {#sec3}
==========

3.1. Identification of the Active Compounds in YCSND {#sec3.1}
----------------------------------------------------

Using the TCMSP database, 546 compounds were retrieved: 53 in Yinchen, 65 in Fuzi, 148 in Ganjiang, and 280 in Gancao. With the criteria of OB≥30% and DL≥0.18, 131 chemical ingredients were screened out: 13 in Yinchen, 21 in Fuzi, 5 in Ganjiang, and 92 in Gancao. As shown in [Table 1](#tab1){ref-type="table"}, actually 126 chemical constituents were accepted in our study after taking out the duplicated parts.

3.2. Constructing the Network of Compound-Target {#sec3.2}
------------------------------------------------

After importing data into Cytoscape 3.5.1, compound-target network ([Figure 1](#fig1){ref-type="fig"}) was constructed. In the network, the orange node (107) represents the YCSND active compound; the blue (138) and purple (112) nodes represent the target protein; the network contains 357 nodes and 1986 edges in total; the degree of a node indicates the number of routes in which the network is connected to the node. The outer blue node is the target which degree is 1; the inside purple node is of the degree more than 2 of the target (communicate orange node). Results of the network topology analysis are as follows: network density (0.031), network heterogeneity (1.603), and shortest paths (127092, 100%). The average degree of nodes is 11.12605, and there are 112 nodes larger than the average degree. The average betweenness centrality of nodes is 0.00529, and there are 52 nodes larger than the average betweenness centrality. The key core nodes (compound or target) are screened based on the topological properties of degree and betweenness centrality of network nodes, as shown in [Table 2](#tab2){ref-type="table"}. It is suggested that the connections between key compounds and target nodes play a pivotal role in the network.

3.3. Analysis of the Targets in the PPI Network {#sec3.3}
-----------------------------------------------

PPI network is conducted to better analyze and understand the mechanisms of YCSND based on the study of protein-protein interactions by using STRING software. A total of 856 interrelations, as well as 179 related targets, are obtained in PPI network after setting the confidence level greater than 0.9 and rejecting the target protein independent of the network. The importance prioritization of key proteins is analyzed according to the degree of the node exported from STRING database. Among them, the JUN value (degree=54) is much higher than that of other protein nodes, which indicates that this protein might play a role of bridge to connect other nodes in PPI network ([Figure 2](#fig2){ref-type="fig"}). The PPI network combined scores were showed in supplementary information file ([available here](#supplementary-material-1){ref-type="supplementary-material"}).

3.4. Gene Ontology (GO) Functional Enrichment Analysis {#sec3.4}
------------------------------------------------------

GO annotation and enrichment of YCSND target protein genes in three aspects of cell composition (CC), molecular function (MF), and biological process (BP) were carried out through the DAVID database. The enrichment results showed that there were 79 enrichment results in the related items of cell composition, involving extracellular space, cytosol, plasma membrane, and other cell components; 161 enrichment results are related to molecular function, which includes enzyme binding, protein heterodimerization activity, and drug binding; 748 enrichment processes are related to the biological processes which cover the response to drug, positive regulation of transcription from RNA polymerase II promoter, response to ethanol, etc. Each p value of enrichment results was calculated (corrected by using the Bonferroni method, p values \< 0.01 were considered to be significantly enriched), ranking p values according to the order from small to large. The top 10 enrichment results are displayed, and details are shown in Tables [3](#tab3){ref-type="table"}, [4](#tab4){ref-type="table"}, and [5](#tab5){ref-type="table"}.

3.5. KEGG Pathway Enrichment Analysis {#sec3.5}
-------------------------------------

The related pathway of YCSND was obtained by KEGG pathway enrichment analysis through the DAVID database. 135 pathways are enriched, and each p value of enrichment results was calculated (corrected by using the Bonferroni method, p values \< 0.01 were considered to be significantly enriched). After sorting the p values, the top 10 are analyzed ([Table 6](#tab6){ref-type="table"}).

4. Discussion {#sec4}
=============

Yinchensini decoction, first recorded in Song dynasty, which can warm Yang to improve jaundice as well as excrete excess water, is used for hepatitis, jaundice, biliary atresia, liver cancer etc. Based on the theory of traditional Chinese medicine, the main indications of Yinchensini decoction includes Yin jaundice, cold extremities, sweating, and drop in blood pressure. As a new subject, network pharmacology can build a component-target network, combine with the proven literature to demonstrate the mechanism of prescription on diseases, and predict the possible mechanism. As the Yinchensini decoction implements its efficacy through multiple targets and multiple approaches, we used network pharmacology to break the limitation of single pharmacology study and explored the mechanism of Yinchensini decoction for its indications more comprehensively. Through algorithm statistics for GO enrichment and KEGG pathway enrichment, we found that the important components of Yinchensini decoction, such as quercetin and kaempferol, may act on key targets, including JUN, RELA, and IL-6, ultimately improving jaundice, inhibiting inflammatory factors, promoting cell proliferation, and regulating RNA polymerase II transcription factor activity via TNF signaling pathway, bladder cancer, and other pathways.

In vitro, quercetin can not only inhibit the proliferation and apoptosis of many tumor cells through multiple signaling pathways, such as the Wnt signaling pathway (cholangiocarcinoma) and the JNK signaling pathway, but enhance the sensitivity of other anticancer drugs and reverse the drug resistance of tumor cells \[[@B5]\]. What is more, Quercetin has all kinds of pharmacological activities such as antioxidant and hepatoprotective effects \[[@B6]\]. It is reported that quercetin can attenuate oxidative stress in alcohol-induced liver disease via heme oxygenase-1 restoration, decreased lipid oxidation, and diminished ROS generation \[[@B7]\].

Prostaglandin G/H synthase 2(PTGS2/COX-2) is closely tied with cancer \[[@B8]\]. Meanwhile, COX-2, as an inflammatory factor, can cause inflammation and oxidative stress injury. COX-2, involved in prostaglandin synthesis, can be detected in several liver pathologies \[[@B9]\]. It is known that liver ischemia-reperfusion injury is common in liver transplantation, shock or acute hemorrhage, with cold limbs and hypotension. Several reports supported that hepatocyte-specific constitutive expression of COX-2 plays a protective role in liver ischemia-reperfusion injury by diminished proinflammatory cytokines (i.e., IL-1*β*, IL-6, and TNF-*α*), increased antiapoptosis (i.e., BAX/BCL-2 radio), and activated AKT and AMPK \[[@B10]--[@B12]\]. Previous studies have suggested that calmodulin is relevant to high-grade serous ovarian cancer \[[@B13]\]. As a high frequency of complications in chronic cholestasis, hypogonadism was observed on the ovary of adult cycling rats with chronic obstructive jaundice, which lead to marked stromal fibrosis and diminished expression of estrogen receptors \[[@B14]\]. Kaempferol and some glycosides of kaempferol have a wide range of pharmacological activities, such as antioxidant, anti-inflammatory, antimicrobial, anticancer, antidiabetic, antiosteoporotic, anxiolytic, analgesic, and antiallergic activities as numerous preclinical studies have shown \[[@B15]\]. Kaempferol is one of the active fractions in Glycosmis pentaphylla (Retz.) DC, which is traditionally used for the treatment of rheumatism, anemia, jaundice, bronchitis, etc. \[[@B16]\].

PPI network analysis shows that score and confidence level of JUN, TP53, FOS, MAPK1, RELA, MYC, MAPK14, MAPK3, EGF, IL6, IL8, and MAPK8 were significantly higher than others. The coding genes of JUN and FOS target protein belong to the immediate early genes of the protooncogenes, which can rapidly be expressed under the stimulation of external factors. The expression products, FOS and JUN, form heterodimer FOS: JUN or homodimer JUN: JUN in a series of the modification process, then combine with the binding sites of activated protein 1(AP -1), and at last have an effect on the expression of target genes \[[@B17]\]. The expression and activity regulation of c-jun is regulated by various protein kinases which play the role of active sites of signaling pathways. C-jun is also involved in the process of tumor cell growth regulation in various growth factors, cytokines and extracellular stimuli \[[@B18]\].

At present, many experimental studies have confirmed that high c-jun expression is highly correlated with the occurrence and prognosis of various malignant tumors \[[@B19]\]. For example, Yang yuewu \[[@B20]\] found that the expression of c-jun in hepatocellular carcinoma (HCC) correlates with HBsAg, AFP, tumor diameter, tumor capsule, tumor vascular invasion and so on, suggesting the c-jun may play an important role in the occurrence and development of liver cancer. RELA is also known as nuclear factor kappa B, a nucleoprotein factor with multidirectional transcriptional regulation effect, which widely exists in various cells of mammals. RELA can activate a variety of related gene transcription and participate in the cell carcinogenesis so that both are confirmedly related to cell growth and apoptosis \[[@B21]\]. A study found that the positive expression rate of the RELA in the tissue of HCC is significantly higher than that of liver tissue adjacent to carcinoma, suggesting that the RELA is closely related to the occurrence of HCC. At the same time, the experiment points out that the expression of the RELA is associated with the malignant degree of tissue of HCC. If cancer tissue becomes worse on differentiation, the expression of RELA will be higher. It can speculate that the RELA could control the transcription of the downstream antiapoptotic gene, thus inhibiting cell apoptosis of liver cancer and causing the proliferation ability of hepatoma carcinoma cell to be strengthened \[[@B22]\].

EGF is an effective mitogenic factor that can stimulate cell division and proliferation in multiple tissues and promote infiltration and metastasis of tumor cells. EGFR is a kind of cell membrane protein kinase receptor which plays a key role in maintaining cell growth and proliferation.

Its excessive activation can spur proliferation and inhibit apoptosis of malignant tumor cells and also can promote tumor metastasis and angiogenesis \[[@B23]\]. The study shows that EGF and EGFR can promote DNA synthesis of HCC by means of the ion channel, signal conduction, and gene expression, thus promoting the occurrence and development of HCC \[[@B24]\]. Jaundice is one of the main symptoms of HCC and YCSND is used to treat Yin jaundice which is a pattern of jaundice in TCM in the clinic. It is speculated that the YCSND can treat jaundice by inhibiting the expression of c-jun, RELA, EGF, and EGFR. In addition, RELA plays an important role in the body\'s immune and inflammatory response and apoptosis regulation and its excessive activation can cause many kinds of pathophysiological reaction. Abdominal pain, nausea, vomiting, fever, and jaundice can be often seen in acute pancreatitis (AP). And the excessive activation of RELA can raise gene expression related to a variety of inflammatory responses in the occurrence and development process of acute pancreatitis, causing large numbers of cytokines and inflammatory mediators being involved in the inflammatory process of AP \[[@B25]\]. Studies have shown that inflammation of the pancreas can be improved effectively by inhibiting activation of RELA, which can reduce expression of TNF alpha mRNA \[[@B26]\].

IL-6 is one of the most biologically active cytokines and has many biological functions. In recent years, numerous experiments have confirmed that the abnormal expression of IL-6 and its receptor is associated with the pathogenesis of tumor and is related with the diagnosis, prognosis, and treatment of tumor \[[@B27]\]. It is reported that the concentration of IL-6 is significantly higher than normal levels in the patients with bile duct carcinoma (BDC), speculating that IL6 has the diagnostic significance of BDC \[[@B28]\]. At the same time, IL6 has an antitumor effect, which can directly or indirectly enhance the tumor-cytotoxic effect of the natural killer cell and cytotoxic lymphocytes \[[@B29]\]. Jaundice is the primary symptom of BDC and YCSND is used to treat Yin jaundice clinically. Thus YCSND is speculated to treat BDC by enhancing the antitumor effect of IL6. MAPK signaling pathway is one of the important signaling pathways of organisms, which is involved in the physiological processes of the cell, such as inflammatory reaction, cell growth, cell differentiation, cell proliferation, and cell survival. MAPK1 is also called ERK2. c-fos is its downstream target gene, closely related to the tumor malignant transformation and proliferation. In addition, MAPK14 belongs to a stress-induced type of MAPK family and the activated MAPK14 highly link to the expression of the downstream gene, c-myc, and induce transposition of BAX as well as enhance the expression of TNF alpha and induce cell physiological dysfunction and apoptosis by activating the hippocampus \[[@B30]\]. Many Chinese herbal medicines and their derivatives can prevent liver cancer by inhibiting the MAPK signaling pathway, such as Phyllanthus amarus, Benzyl sulforaphane, and Schizocarps plantaginea \[[@B31]--[@B33]\]. So it can be speculated that YCSND can treat jaundice caused by HCC or AP by inhibiting MAPK signaling pathway which can inhibit inflammation and tumor proliferation.

As the purpose of this paper is to explore how YCSND plays its therapeutic role through its effective components acting on multiple targets and multiple pathways, KEGG were used to enrich pathways. And based on a large number of reported literatures, each link of the signal pathways is depicted in the KEGG database. Therefore, we can analyze the cellular components, biochemical processes, and molecular functions from the enriched pathways to corroborate the GO enriched results.

Hepatitis B is one of the significantly enriched pathways, which composes of many signal pathways and involves in complex biological processes. Double-stranded relaxed circular DNA (RC-DNA) is the main genetic material of hepatitis B virus. After entering the hepatocyte nucleus, RC-DNA is transformed into cccDNA. Then all viral RNAs including the pregenomic RNA (pgRNA) start transcribing through cccDNA, and HBV core and polymerase II are translated \[[@B34]\]. Ren JH \[[@B35]\] found that SIRT3 restricts the transcription of HBV by decreased host RNA polymerase II and transcription factor binding. Thus, YCSND may inhibit reverse transcription of HBV by regulating RNA polymerase II and transcription factors, which reduce the inflammatory response in HBV patients.

It is well known that many proteins are embedded in the surface of cell membrane and endoplasmic reticulum, which mediate biochemical reactions in the body and thus guarantee normal life activities. TNF is mainly produced by activatory mononuclear macrophages and is an important inflammatory factor. Activated TNF binds to its receptors (TNFR1, TNFR2) in the cell membrane resulting in the activation of many genes and initiating NF-kappa B pathway and the MAPK pathway \[[@B36]\]. TNF signaling pathway can mediate the inflammatory immune response together with the positive regulation of mRNA expression of transcription factors (c-fos, c-jun) and the level of inflammatory cytokines etc. \[[@B37]\]. There is a research showing that a large amount of TNF alpha which can be involved in inducing the expression of IL-1, IL-6, IL-8, and its own genes can be released in process of AP, resulting in a large release of cytokines and inflammatory mediators and causing the necrosis of pancreatic tissue \[[@B38]\]. Thus TNF signaling pathway is involved in the occurrence and development of AP as an important proinflammatory cytokine. Jaundice is one of the main symptoms of AP and YCSND is used to treat Yin jaundice. So it can be speculated that YCSND can treat jaundice by inhibiting the expression of TNF signaling pathway. Subsequently, the inflammation of AP is reduced because the generation of inflammatory mediators and cytokines is reduced.
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The chemical ingredients of YCSND were extracted from TCMSP platform to support the findings of this study. The important nodes of YCSND compound-target network used to support the findings of this study are included within the article. The PPI network used to rank the importance of targets is performed by using STRING software. The degree of targets was collected from STRING software after setting the confidence level greater than 0.9 and rejecting the target protein independent of the network. The gene ontology (GO) functional enrichment analysis includes TOP10 of composition (CC), molecular function (MF), biological process (BP), and KEGG pathway enrichment used to elaborate the pharmacological mechanism of YCSD, which are included within the article. Besides, the rest of them used to support the findings of this study are included within the supplementary information file(s).
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![The compound-target network of YCSND.](ECAM2018-2178610.001){#fig1}

![The PPI network of YCSND (the larger the node, the deeper the color, representing the greater the degree of the node).](ECAM2018-2178610.002){#fig2}

###### 

Information for 126 chemical ingredients of YCSD.

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  **Mol ID**   **Molecule Name**                                                                                                                                                                                                                                                         **OB**%   **DL**   **Source**
  ------------ ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------- -------- ------------
  MOL004609    Areapillin                                                                                                                                                                                                                                                                48.96     0.41     Yinchen

  MOL005573    Genkwanin                                                                                                                                                                                                                                                                 37.13     0.24     

  MOL007274    Skrofulein                                                                                                                                                                                                                                                                30.35     0.3      

  MOL008039    Isoarcapillin                                                                                                                                                                                                                                                             57.4      0.41     

  MOL008040    Eupalitin                                                                                                                                                                                                                                                                 46.11     0.33     

  MOL008041    Eupatolitin                                                                                                                                                                                                                                                               42.55     0.37     

  MOL008043    Capillarisin                                                                                                                                                                                                                                                              57.56     0.31     

  MOL008045    4\'-Methylcapillarisin                                                                                                                                                                                                                                                    72.18     0.35     

  MOL008046    Demethoxycapillarisin                                                                                                                                                                                                                                                     52.33     0.25     

  MOL008047    Artepillin A                                                                                                                                                                                                                                                              68.32     0.24     

  MOL002211    11,14-eicosadienoic acid                                                                                                                                                                                                                                                  39.99     0.2      Fuzi

  MOL002388    Delphin_qt                                                                                                                                                                                                                                                                57.76     0.28     

  MOL002392    Deltoin                                                                                                                                                                                                                                                                   46.69     0.37     

  MOL002393    Demethyldelavaine A                                                                                                                                                                                                                                                       34.52     0.18     

  MOL002394    Demethyldelavaine B                                                                                                                                                                                                                                                       34.52     0.18     

  MOL002395    Deoxyandrographolide                                                                                                                                                                                                                                                      56.3      0.31     

  MOL002397    Karakoline                                                                                                                                                                                                                                                                51.73     0.73     

  MOL002398    Karanjin                                                                                                                                                                                                                                                                  69.56     0.34     

  MOL002401    Neokadsuranic acid B                                                                                                                                                                                                                                                      43.1      0.85     

  MOL002406    2,7-Dideacetyl-2,7-dibenzoyl-taxayunnanine F                                                                                                                                                                                                                              39.43     0.38     

  MOL002410    Benzoylnapelline                                                                                                                                                                                                                                                          34.06     0.53     

  MOL002415    6-Demethyldesoline                                                                                                                                                                                                                                                        51.87     0.66     

  MOL002416    deoxyaconitine                                                                                                                                                                                                                                                            30.96     0.24     

  MOL002419    (R)-Norcoclaurine                                                                                                                                                                                                                                                         82.54     0.21     

  MOL002421    Ignavine                                                                                                                                                                                                                                                                  84.08     0.25     

  MOL002422    Isotalatizidine                                                                                                                                                                                                                                                           50.82     0.73     

  MOL002423    Jesaconitine                                                                                                                                                                                                                                                              33.41     0.19     

  MOL002433    (3R,8S,9R,10R,13R,14S,17R)-3-hydroxy-4,4,9,13,14-pentamethyl-17-\[(E,2R)-6-methyl-7-\[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-\[\[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl\]oxymethyl\]oxan-2-yl\]oxyhept-5-en-2-yl\]-1,2,3,7,8,10,12,15,16,17-decahydr   41.52     0.22     

  MOL002434    Carnosifloside I_qt                                                                                                                                                                                                                                                       38.16     0.8      

  MOL000538    Hypaconitine                                                                                                                                                                                                                                                              31.39     0.26     

  MOL002464    1-Monolinolein                                                                                                                                                                                                                                                            37.18     0.3       

  MOL002501    \[(1S)-3-\[(E)-but-2-enyl\]-2-methyl-4-oxo-1-cyclopent-2-enyl\] (1R,3R)-3-\[(E)-3-methoxy-2-methyl-3-oxoprop-1-enyl\]-2,2-dimethylcyclopropane-1-carboxylate                                                                                                              62.52     0.31     Ganjiang

  MOL002514    Sexangularetin                                                                                                                                                                                                                                                            62.86     0.3       

  MOL004898    (E)-3-\[3,4-dihydroxy-5-(3-methylbut-2-enyl)phenyl\]-1-(2,4-dihydroxyphenyl)prop-2-en-1-one                                                                                                                                                                               46.27     0.31      

  MOL004903    Liquiritin                                                                                                                                                                                                                                                                65.69     0.74      

  MOL004904    Licopyranocoumarin                                                                                                                                                                                                                                                        80.36     0.65      

  MOL004905    3,22-Dihydroxy-11-oxo-delta(12)-oleanene-27-alpha-methoxycarbonyl-29-oic acid                                                                                                                                                                                             34.32     0.55      

  MOL004907    Glyzaglabrin                                                                                                                                                                                                                                                              61.07     0.35      

  MOL004908    Glabridin                                                                                                                                                                                                                                                                 53.25     0.47      

  MOL004910    Glabranin                                                                                                                                                                                                                                                                 52.9      0.31      

  MOL004911    Glabrene                                                                                                                                                                                                                                                                  46.27     0.44      

  MOL004912    Glabrone                                                                                                                                                                                                                                                                  52.51     0.5       

  MOL004913    1,3-dihydroxy-9-methoxy-6-benzofurano\[3,2-c\]chromenone                                                                                                                                                                                                                  48.14     0.43      

  MOL004914    1,3-dihydroxy-8,9-dimethoxy-6-benzofurano\[3,2-c\]chromenone                                                                                                                                                                                                              62.9      0.53      

  MOL004915    Eurycarpin A                                                                                                                                                                                                                                                              43.28     0.37      

  MOL004917    Glycyroside                                                                                                                                                                                                                                                               37.25     0.79      

  MOL004924    (-)-Medicocarpin                                                                                                                                                                                                                                                          40.99     0.95     Gancao

  MOL004935    Sigmoidin-B                                                                                                                                                                                                                                                               34.88     0.41      

  MOL004941    (2R)-7-hydroxy-2-(4-hydroxyphenyl)chroman-4-one                                                                                                                                                                                                                           71.12     0.18      

  MOL004945    (2S)-7-hydroxy-2-(4-hydroxyphenyl)-8-(3-methylbut-2-enyl)chroman-4-one                                                                                                                                                                                                    36.57     0.32      

  MOL004948    Isoglycyrol                                                                                                                                                                                                                                                               44.7      0.84      

  MOL004949    Isolicoflavonol                                                                                                                                                                                                                                                           45.17     0.42      

  MOL004957    HMO                                                                                                                                                                                                                                                                       38.37     0.21      

  MOL004959    1-Methoxyphaseollidin                                                                                                                                                                                                                                                     69.98     0.64      

  MOL004961    Quercetin der.                                                                                                                                                                                                                                                            46.45     0.33      

  MOL004966    3\'-Hydroxy-4\'-O-Methylglabridin                                                                                                                                                                                                                                         43.71     0.57      

  MOL000497    licochalcone a                                                                                                                                                                                                                                                            40.79     0.29      

  MOL004974    3\'-Methoxyglabridin                                                                                                                                                                                                                                                      46.16     0.57      

  MOL004978    2-\[(3R)-8,8-dimethyl-3,4-dihydro-2H-pyrano\[6,5-f\]chromen-3-yl\]-5-methoxyphenol                                                                                                                                                                                        36.21     0.52      

  MOL004980    Inflacoumarin A                                                                                                                                                                                                                                                           39.71     0.33      

  MOL004985    icos-5-enoic acid                                                                                                                                                                                                                                                         30.7      0.2       

  MOL004988    Kanzonol F                                                                                                                                                                                                                                                                32.47     0.89      

  MOL004989    6-prenylated eriodictyol                                                                                                                                                                                                                                                  39.22     0.41      

  MOL004990    7,2\',4\'-trihydroxy---5-methoxy-3---arylcoumarin                                                                                                                                                                                                                         83.71     0.27      

  MOL004991    7-Acetoxy-2-methylisoflavone                                                                                                                                                                                                                                              38.92     0.26      

  MOL004993    8-prenylated eriodictyol                                                                                                                                                                                                                                                  53.79     0.4       

  MOL004996    gadelaidic acid                                                                                                                                                                                                                                                           30.7      0.2       

  MOL000500    Vestitol                                                                                                                                                                                                                                                                  74.66     0.21      

  MOL005000    Gancaonin G                                                                                                                                                                                                                                                               60.44     0.39      

  MOL005001    Gancaonin H                                                                                                                                                                                                                                                               50.1      0.78      

  MOL005003    Licoagrocarpin                                                                                                                                                                                                                                                            58.81     0.58      

  MOL005007    Glyasperins M                                                                                                                                                                                                                                                             72.67     0.59      

  MOL005008    Glycyrrhiza flavonol A                                                                                                                                                                                                                                                    41.28     0.6       

  MOL005012    Licoagroisoflavone                                                                                                                                                                                                                                                        57.28     0.49      

  MOL005013    18*α*-hydroxyglycyrrhetic acid                                                                                                                                                                                                                                            41.16     0.71      

  MOL005016    Odoratin                                                                                                                                                                                                                                                                  49.95     0.3       

  MOL005017    Phaseol                                                                                                                                                                                                                                                                   78.77     0.58      

  MOL005018    Xambioona                                                                                                                                                                                                                                                                 54.85     0.87      

  MOL001484    Inermine                                                                                                                                                                                                                                                                  75.18     0.54      

  MOL001792    DFV                                                                                                                                                                                                                                                                       32.76     0.18      

  MOL000211    Mairin                                                                                                                                                                                                                                                                    55.38     0.78      

  MOL002311    Glycyrol                                                                                                                                                                                                                                                                  90.78     0.67      

  MOL000239    Jaranol                                                                                                                                                                                                                                                                   50.83     0.29      

  MOL002565    Medicarpin                                                                                                                                                                                                                                                                49.22     0.34      

  MOL003656    Lupiwighteone                                                                                                                                                                                                                                                             51.64     0.37      

  MOL003896    7-Methoxy-2-methyl isoflavone                                                                                                                                                                                                                                             42.56     0.2       

  MOL000392    Formononetin                                                                                                                                                                                                                                                              69.67     0.21      

  MOL000417    Calycosin                                                                                                                                                                                                                                                                 47.75     0.24      

  MOL000422    Kaempferol                                                                                                                                                                                                                                                                41.88     0.24      

  MOL004328    Naringenin                                                                                                                                                                                                                                                                59.29     0.21      

  MOL004805    (2S)-2-\[4-hydroxy-3-(3-methylbut-2-enyl)phenyl\]-8,8-dimethyl-2,3-dihydropyrano\[2,3-f\]chromen-4-one                                                                                                                                                                    31.79     0.72      

  MOL004806    euchrenone                                                                                                                                                                                                                                                                30.29     0.57      

  MOL004808    Glyasperin B                                                                                                                                                                                                                                                              65.22     0.44      

  MOL004810    Glyasperin F                                                                                                                                                                                                                                                              75.84     0.54      

  MOL004811    Glyasperin C                                                                                                                                                                                                                                                              45.56     0.4       

  MOL004814    Isotrifoliol                                                                                                                                                                                                                                                              31.94     0.42      

  MOL004815    (E)-1-(2,4-dihydroxyphenyl)-3-(2,2-dimethylchromen-6-yl)prop-2-en-1-one                                                                                                                                                                                                   39.62     0.35      

  MOL004820    Kanzonol W                                                                                                                                                                                                                                                                50.48     0.52      

  MOL004824    (2S)-6-(2,4-dihydroxyphenyl)-2-(2-hydroxypropan-2-yl)-4-methoxy-2,3-dihydrofuro\[3,2-g\]chromen-7-one                                                                                                                                                                     60.25     0.63      

  MOL004827    Semilicoisoflavone B                                                                                                                                                                                                                                                      48.78     0.55      

  MOL004828    Glepidotin A                                                                                                                                                                                                                                                              44.72     0.35      

  MOL004829    Glepidotin B                                                                                                                                                                                                                                                              64.46     0.34      

  MOL004833    Phaseolinisoflavan                                                                                                                                                                                                                                                        32.01     0.45      

  MOL004835    Glypallichalcone                                                                                                                                                                                                                                                          61.6      0.19      

  MOL004838    8-(6-hydroxy-2-benzofuranyl)-2,2-dimethyl-5-chromenol                                                                                                                                                                                                                     58.44     0.38      

  MOL004841    Licochalcone B                                                                                                                                                                                                                                                            76.76     0.19      

  MOL004848    licochalcone G                                                                                                                                                                                                                                                            49.25     0.32      

  MOL004849    3-(2,4-dihydroxyphenyl)-8-(1,1-dimethylprop-2-enyl)-7-hydroxy-5-methoxy-coumarin                                                                                                                                                                                          59.62     0.43      

  MOL004855    Licoricone                                                                                                                                                                                                                                                                63.58     0.47      

  MOL004856    Gancaonin A                                                                                                                                                                                                                                                               51.08     0.4       

  MOL004857    Gancaonin B                                                                                                                                                                                                                                                               48.79     0.45      

  MOL004860    licorice glycoside E                                                                                                                                                                                                                                                      32.89     0.27      

  MOL004863    3-(3,4-dihydroxyphenyl)-5,7-dihydroxy-8-(3-methylbut-2-enyl)chromone                                                                                                                                                                                                      66.37     0.41      

  MOL004864    5,7-dihydroxy-3-(4-methoxyphenyl)-8-(3-methylbut-2-enyl)chromone                                                                                                                                                                                                          30.49     0.41      

  MOL004866    2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-6-(3-methylbut-2-enyl)chromone                                                                                                                                                                                                      44.15     0.41      

  MOL004879    Glycyrin                                                                                                                                                                                                                                                                  52.61     0.47      

  MOL004882    Licocoumarone                                                                                                                                                                                                                                                             33.21     0.36      

  MOL004883    Licoisoflavone                                                                                                                                                                                                                                                            41.61     0.42      

  MOL004884    Licoisoflavone B                                                                                                                                                                                                                                                          38.93     0.55      

  MOL004885    Licoisoflavanone                                                                                                                                                                                                                                                          52.47     0.54      

  MOL004891    Shinpterocarpin                                                                                                                                                                                                                                                           80.3      0.73      

  MOL005020    Dehydroglyasperin C                                                                                                                                                                                                                                                       53.82     0.37      

  MOL000354    Isorhamnetin                                                                                                                                                                                                                                                              49.6      0.31     Yinchen\
                                                                                                                                                                                                                                                                                                            Gancao

  MOL000358    Beta-sitosterol                                                                                                                                                                                                                                                           36.91     0.75     Yinchen\
                                                                                                                                                                                                                                                                                                            Ganjiang

  MOL000098    Quercetin                                                                                                                                                                                                                                                                 46.43     0.28     Yinchen\
                                                                                                                                                                                                                                                                                                            Gancao

  MOL000359    Sitosterol                                                                                                                                                                                                                                                                36.91     0.75     Fuzi\
                                                                                                                                                                                                                                                                                                            Ganjiang\
                                                                                                                                                                                                                                                                                                            Gancao
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

Important node of YCSND compound-target network.

  **Node Name**                                                                        **Node Type**   **Degree**   **Betweenness Centrality**
  ------------------------------------------------------------------------------------ --------------- ------------ ----------------------------
  Quercetin                                                                            Compound        154          0.51220399
  Prostaglandin G/H synthase 2                                                         Target          98           0.09990361
  Estrogen receptor                                                                    Target          80           0.03095638
  Calmodulin                                                                           Target          77           0.01919701
  Heat shock protein HSP 90                                                            Target          74           0.06433216
  Nitric oxide synthase, inducible                                                     Target          74           0.01539794
  Androgen receptor                                                                    Target          73           0.03326497
  Kaempferol                                                                           Compound        63           0.10360504
  Trypsin-1                                                                            Target          63           0.02571407
  Cell division protein kinase 2                                                       Target          62           0.00804666
  Glycogen synthase kinase-3 beta                                                      Target          61           0.0087541
  Peroxisome proliferator-activated receptor gamma                                     Target          61           0.02602051
  Proto-oncogene serine/threonine-protein kinase Pim-1                                 Target          61           0.00731391
  Estrogen receptor beta                                                               Target          60           0.00760087
  Coagulation factor Xa                                                                Target          55           0.01878226
  Cyclin-A2                                                                            Target          53           0.00546001
  Nuclear receptor coactivator 2                                                       Target          52           0.05181668
  Prostaglandin G/H synthase 1                                                         Target          52           0.04921123
  Sodium channel protein type 5 subunit alpha                                          Target          51           0.02323399
  Dipeptidyl peptidase IV                                                              Target          45           0.02031966
  7-Methoxy-2-methyl isoflavone                                                        Compound        43           0.0274993
  Formononetin                                                                         Compound        39           0.0438877
  beta-sitosterol                                                                      Compound        38           0.06644929
  Thrombin                                                                             Target          38           0.01452236
  Isorhamnetin                                                                         Compound        37           0.03169965
  Naringenin                                                                           Compound        37           0.1201062
  Medicarpin                                                                           Compound        34           0.02391904
  mRNA of PKA Catalytic Subunit C-alpha                                                Target          34           0.03269624
  licochalcone a                                                                       Compound        32           0.02913105
  2-\[(3R)-8,8-dimethyl-3,4-dihydro-2H-pyrano\[6,5-f\]chromen-3-yl\]-5-methoxyphenol   Compound        31           0.00718614
  Beta-2 adrenergic receptor                                                           Target          31           0.01440293
  DNA topoisomerase II                                                                 Target          31           0.00830063
  shinpterocarpin                                                                      Compound        30           0.01309466
  Vestitol                                                                             Compound        30           0.00877921
  Licoagrocarpin                                                                       Compound        29           0.00658159
  Retinoic acid receptor RXR-alpha                                                     Target          28           0.01008831
  Glypallichalcone                                                                     Compound        27           0.00712433
  Glyasperins M                                                                        Compound        26           0.00616704
  Acetylcholinesterase                                                                 Target          24           0.00976155
  Coagulation factor VII                                                               Target          22           0.00700284
  Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit, gamma isoform      Target          17           0.01365074
  Potassium voltage-gated channel subfamily H member 2                                 Target          16           0.00643202
  Nitric-oxide synthase, endothelial                                                   Target          14           0.00565094
  Demethoxycapillarisin                                                                Compound        13           0.01972483

###### 

Gene ontology term, cellular component, direct (Top 10).

  **GOTERM - CC - DIRECT**           **Count**   **P value**                           
  ---------------------------------- ----------- ------------------------------------- -------------
  extracellular space                66          ![](ECAM2018-2178610.tab3.i001.jpg)   1.2×10^−19^
  Cytosol                            94          ![](ECAM2018-2178610.tab3.i002.jpg)   1.3×10^−12^
  plasma membrane                    103         ![](ECAM2018-2178610.tab3.i003.jpg)   1.3×10^−10^
  membrane raft                      19          ![](ECAM2018-2178610.tab3.i004.jpg)   6.0×10^−10^
  external side of plasma membrane   18          ![](ECAM2018-2178610.tab3.i005.jpg)   7.2×10^−9^
  extracellular exosome              75          ![](ECAM2018-2178610.tab3.i006.jpg)   1.3×10^−8^
  extracellular region               52          ![](ECAM2018-2178610.tab3.i007.jpg)   1.5×10^−8^
  Caveola                            11          ![](ECAM2018-2178610.tab3.i008.jpg)   2.0×10^−8^
  endoplasmic reticulum membrane     34          ![](ECAM2018-2178610.tab3.i009.jpg)   1.2×10^−7^
  endoplasmic reticulum              33          ![](ECAM2018-2178610.tab3.i010.jpg)   1.5×10^−7^

###### 

Gene ontology term, molecular function, direct (Top 10).

  **GOTERM - MF -- DIRECT**                                                                         **Count**   **P value**                           
  ------------------------------------------------------------------------------------------------- ----------- ------------------------------------- -------------
  enzyme binding                                                                                    49          ![](ECAM2018-2178610.tab4.i001.jpg)   1.4×10^−33^
  protein heterodimerization activity                                                               38          ![](ECAM2018-2178610.tab4.i002.jpg)   4.9×10^−17^
  drug binding                                                                                      18          ![](ECAM2018-2178610.tab4.i003.jpg)   8.2×10^−16^
  protein homodimerization activity                                                                 45          ![](ECAM2018-2178610.tab4.i004.jpg)   1.6×10^−15^
  identical protein binding                                                                         42          ![](ECAM2018-2178610.tab4.i005.jpg)   3.9×10^−13^
  RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding   12          ![](ECAM2018-2178610.tab4.i006.jpg)   2.7×10^−12^
  transcription factor binding                                                                      25          ![](ECAM2018-2178610.tab4.i007.jpg)   6.7×10^−12^
  protein kinase binding                                                                            28          ![](ECAM2018-2178610.tab4.i008.jpg)   1.4×10^−11^
  protein binding                                                                                   183         ![](ECAM2018-2178610.tab4.i009.jpg)   2.0×10^−11^
  steroid hormone receptor activity                                                                 13          ![](ECAM2018-2178610.tab4.i010.jpg)   2.8×10^−11^

###### 

Gene ontology term, biological process, direct (Top 10).

  **GOTERM - BP - DIRECT**                                               **Count**   **P value**                           
  ---------------------------------------------------------------------- ----------- ------------------------------------- -------------
  response to drug                                                       40          ![](ECAM2018-2178610.tab5.i001.jpg)   2.2×10^−25^
  positive regulation of transcription from RNA polymerase II promoter   58          ![](ECAM2018-2178610.tab5.i002.jpg)   2.0×10^−19^
  response to ethanol                                                    22          ![](ECAM2018-2178610.tab5.i003.jpg)   3.6×10^−18^
  positive regulation of gene expression                                 30          ![](ECAM2018-2178610.tab5.i004.jpg)   2.6×10^−17^
  aging                                                                  24          ![](ECAM2018-2178610.tab5.i005.jpg)   3.8×10^−16^
  positive regulation of transcription, DNA-templated                    38          ![](ECAM2018-2178610.tab5.i006.jpg)   1.5×10^−15^
  xenobiotic glucuronidation                                             9           ![](ECAM2018-2178610.tab5.i007.jpg)   1.9×10^−14^
  negative regulation of the fatty acid metabolic process                9           ![](ECAM2018-2178610.tab5.i008.jpg)   1.9×10^−14^
  response to estradiol                                                  18          ![](ECAM2018-2178610.tab5.i009.jpg)   2.2×10^−14^
  positive regulation of nitric oxide biosynthetic process               14          ![](ECAM2018-2178610.tab5.i010.jpg)   3.2×10^−14^

###### 

KEGG pathway enrichment (Top 10).

  **KEGG Pathway**                            **Count**   **P value**                           
  ------------------------------------------- ----------- ------------------------------------- -------------
  Pathways in cancer                          60          ![](ECAM2018-2178610.tab6.i001.jpg)   3.7×10^−25^
  Hepatitis B                                 39          ![](ECAM2018-2178610.tab6.i002.jpg)   4.0×10^−25^
  Pancreatic cancer                           28          ![](ECAM2018-2178610.tab6.i003.jpg)   4.2×10^−24^
  Prostate cancer                             29          ![](ECAM2018-2178610.tab6.i004.jpg)   3.2×10^−21^
  TNF signaling pathway                       29          ![](ECAM2018-2178610.tab6.i005.jpg)   8.7×10^−19^
  Bladder cancer                              20          ![](ECAM2018-2178610.tab6.i006.jpg)   2.3×10^−18^
  Chagas disease (American trypanosomiasis)   27          ![](ECAM2018-2178610.tab6.i007.jpg)   7.2×10^−17^
  Toxoplasmosis                               28          ![](ECAM2018-2178610.tab6.i008.jpg)   2.0×10^−16^
  Nonsmall cell lung cancer                   20          ![](ECAM2018-2178610.tab6.i009.jpg)   2.7×10^−15^
  Hepatitis C                                 28          ![](ECAM2018-2178610.tab6.i010.jpg)   5.4×10^−15^

[^1]: Academic Editor: Shuang-En Chuang
